New Cosponsor — Oct 15, 2009
New Cosponsor: Rep. Don Young [R-AK0]
The bill now has 16 cosponsors (8 Republicans, 8 Democrats).
GovTrack Insider, our Kickstarter-backed work to summarize bills in Congress, has resumed. Here’s what we’ve been up to:
Mar 11, 2009
111th Congress, 2009–2010
This bill was introduced on March 11, 2009, in a previous session of Congress, but was not enacted.
Representative for California's 30th congressional district
Read Text »
Last Updated: Mar 11, 2009
Length: 52 pages
To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 1427”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 1427 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act. Retrieved from https://www.govtrack.us/congress/bills/111/hr1427
“H.R. 1427 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act.” www.GovTrack.us. 2009. February 14, 2016 <https://www.govtrack.us/congress/bills/111/hr1427>
|title=H.R. 1427 (111th)
|accessdate=February 14, 2016
|author=111th Congress (2009)
|date=March 11, 2009
|quote=Promoting Innovation and Access to Life-Saving Medicine Act